Department Head
Oslo University Hospital
Oslo, Oslo, Norway
Dr. Leonardo A. Meza-Zepeda is the Head of the Department of Core Facilities and Head of the Translational Genomics Group at the Institute for Cancer Research at Oslo University Hospital. Meza-Zepeda received his degree in Biochemistry in Chile and later a Ph.D. in Cancer Genomics from the University of Oslo. His research has focused on understanding cancer genome biology in soft tissue and bone tumours, with particular emphasis on identifying and characterising somatic changes. During the last years, he has extensively used high-throughput sequencing technologies to characterise genomic and transcriptomic changes in different cancer types and use blood as a liquid biopsy to detect and monitor circulating tumour DNA in the blood of cancer patients. Meza-Zepeda has been instrumental in developing high-throughput genomic analysis in Norway, from large-scale high-throughput cancer sequencing to single-cell and spatial transcriptomics analysis. He has led the cancer sequencing technology platform for the Norwegian Cancer Genomics Consortium (NCGC), and is a principal investigator of the Norwegian Consortium for Sequencing and Personalised Medicine (NorSeq), running the national platform for high-throughput sequencing. Meza-Zepeda is also actively implementing advanced precision diagnostics in Norway, for the stratification of cancer patients into clinical trials.
Paper 63 - A NOVEL GENOMIC SIGNATURE FOR STRATIFICATION OF HIGH-RISK GASTROINTESTINAL STROMAL TUMOR
Saturday, November 15, 2025
9:00 AM - 10:30 AM EST
Disclosure information not submitted.
